Are you between 18 and 45 years of age and diagnosed with multiple sclerosis, without MS relapses within the past year? Are you currently prescribed with MS medication? If so, you may be able to participate in a research study examining whether a switch to a high-efficacy medication- Ofatumumab, would work better for you than your current treatment.

If you have a child with MS who is between 10 and 18 years old who has experienced at least one MS episode in the last 12 months, or at least 2 episodes in the last 24 months, your child could qualify for a study testing a drug that is currently used to treat adults with MS.